Literature DB >> 8667031

Nerve growth factor and ras regulate beta-amyloid precursor protein gene expression in PC12 cells.

J M Cosgaya1, M J Latasa, A Pascual.   

Abstract

The beta-amyloid protein, the major component of the vascular and plaque amyloid deposits that characterize Alzheimer's disease, derives from a larger beta-amyloid precursor protein (APP) that is expressed in both neural and nonneural cells. An increased expression of APP might actively contribute to the development of the pathology; however, the mechanisms involved in the regulation of APP gene expression are not yet well understood. In PC12 cells, a rat pheochromocytoma cell line, we have demonstrated that nerve growth factor (NGF) induces the APP gene expression and increases APP mRNA levels in the presence of 0.5 or 15% serum. Expression of activated ras in the PC12 cell subline UR61 also leads to a significant increase in content of APP transcripts, and a dominant negative mutant of ras blocks the NGF-induced response. Other ligands of tyrosine kinase receptors, such as fibroblast growth factor, which causes morphological differentiation, or epidermal growth factor, which induces cell growth, also increase APP mRNA levels in PC12 cells. These results suggest that ras mediates the induction of APP gene expression by NGF and other ligands of tyrosine kinase receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8667031     DOI: 10.1046/j.1471-4159.1996.67010098.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Inhibition of the NGF and IL-1beta-induced expression of Alzheimer's amyloid precursor protein by antisense oligonucleotides.

Authors:  K A Chang; S H Kim; Y Sakaki; H S Kim; C W Park; Y H Suh
Journal:  J Mol Neurosci       Date:  1999-02       Impact factor: 3.444

Review 2.  The role of glycoproteins in neural development function, and disease.

Authors:  K C Breen; C M Coughlan; F D Hayes
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

3.  Activation of amyloid precursor protein processing by growth factors is dependent on Ras GTPase activity.

Authors:  Loredana Amigoni; Michela Ceriani; Fiorella Belotti; Giuseppina Minopoli; Enzo Martegani
Journal:  Neurochem Res       Date:  2010-12-15       Impact factor: 3.996

Review 4.  New insights into the role of fibroblast growth factors in Alzheimer's disease.

Authors:  Ramy Alam; Yara Mrad; Hussein Hammoud; Zahraa Saker; Youssef Fares; Elias Estephan; Hisham F Bahmad; Hayat Harati; Sanaa Nabha
Journal:  Mol Biol Rep       Date:  2021-11-03       Impact factor: 2.316

5.  Down-Regulation of Insulin Like Growth Factor 1 Involved in Alzheimer's Disease via MAPK, Ras, and FoxO Signaling Pathways.

Authors:  Kexin Kang; Jun Bai; Shanshan Zhong; Rongwei Zhang; Xiaoqian Zhang; Ying Xu; Mei Zhao; Chuansheng Zhao; Zhike Zhou
Journal:  Oxid Med Cell Longev       Date:  2022-05-04       Impact factor: 7.310

6.  Differences in extracellular matrix production and basic fibroblast growth factor response in skin fibroblasts from sporadic and familial Alzheimer's disease.

Authors:  Catia Bellucci; Cinzia Lilli; Tiziano Baroni; Lucilla Parnetti; Sandro Sorbi; Carla Emiliani; Eleonora Lumare; Paolo Calabresi; Stefania Balloni; Maria Bodo
Journal:  Mol Med       Date:  2007 Sep-Oct       Impact factor: 6.354

7.  Ras signal triggers β-amyloid precursor protein (APP) expression.

Authors:  Natalia Mora; Paula Santa Bárbara Ruiz; Nuno Ferreira; Florenci Serras
Journal:  Small GTPases       Date:  2013-05-06

8.  Effects of nerve growth factor and nitric oxide synthase inhibitors on amyloid precursor protein mRNA levels and protein stability.

Authors:  Janet C Mackinnon; Patricia Huether; Bettina E Kalisch
Journal:  Open Biochem J       Date:  2012-04-19

9.  Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.

Authors:  Lisa Kirouac; Alexander J Rajic; David H Cribbs; Jaya Padmanabhan
Journal:  eNeuro       Date:  2017-03-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.